Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: A case-control study in Japan

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Lin, Yingsong ^a   Ueda, Junko ^a   Yagyu, Kiyoko ^a   Ishii, Hiroshi ^b   Ueno, Makoto ^c   Egawa, Naoto ^d,e   Nakao, Haruhisa ^a   Mori, Mitsuru ^f   Matsuo, Keitaro ^g   Kikuchi, Shogo ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

Author keywords

Case control study; Pancreatic cancer; Rs9939609; The fat mass and obesity associated gene

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PANCREAS TUMOR; RISK; RISK FACTOR;

FTO PROTEIN, HUMAN; PROTEIN;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS;

EID: 84879832109     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-337     Document Type: Article

References (34)

1. Statistics and Information Department Vital Statistics of Japan 2010, Tokyo: Minister of Health and Welfare, Statistics and Information Department.
2. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008, 393:535-545. 10.1007/s00423-007-0266-2, 18193270.
3. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, Zhang H, Li Z. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer 2011, 47:1928-1937. 10.1016/j.ejca.2011.03.003, 21458985.
4. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004, 4:579-591.
5. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638. 10.1056/NEJMoa021423, 12711737.
6. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005, 93:1062-1067. 10.1038/sj.bjc.6602819, 2361672, 16234822.
7. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001, 286:921-929. 10.1001/jama.286.8.921, 11509056.
8. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer 2007, 120:1993-1998. 10.1002/ijc.22535, 17266034.
9. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ, Norat T. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 2012, 23:843-852. 10.1093/annonc/mdr398, 21890910.
10. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003, 89:519-523. 10.1038/sj.bjc.6601140, 2394383, 12888824.
11. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578. 10.1016/S0140-6736(08)60269-X, 18280327.
12. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, Petersen GM, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Amundadottir L, Bamlet WR, Barricarte A, Bingham SA, Boeing H, Boutron-Ruault MC, Buring JE, Chanock SJ, Clipp S, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Hutchinson A, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010, 170:791-802. 10.1001/archinternmed.2010.63, 2920035, 20458087.
13. Jiao L, Berrington de Gonzalez A, Hartge P, Pfeiffer RM, Park Y, Freedman DM, Gail MH, Alavanja MC, Albanes D, Beane Freeman LE, Chow WH, Huang WY, Hayes RB, Hoppin JA, Ji BT, Leitzmann MF, Linet MS, Meinhold CL, Schairer C, Schatzkin A, Virtamo J, Weinstein SJ, Zheng W, Stolzenberg-Solomon RZ. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 2010, 21:1305-1314. 10.1007/s10552-010-9558-x, 2904431, 20383573.
14. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English DR, Folsom AR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Horn-Ross PL, Larsson SC, Leitzmann M, Männistö S, Marshall JR, Miller AB, Patel AV, Rohan TE, Stolzenberg-Solomon RZ, Verhage BA, Virtamo J, Willcox BJ, Wolk A, Ziegler RG, Smith-Warner SA. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 2011, 129:1708-1717. 10.1002/ijc.25794, 3073156, 21105029.
15. Luo J, Iwasaki M, Inoue M, Sasazuki S, Otani T, Ye W, Tsugane S, JPHC Study Group Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC stud. Cancer Causes Control 2007, 18:603-612. 10.1007/s10552-007-9002-z, 17401636, JPHC Study Group.
16. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y, Kurosawa M, Kawamura T, Motohashi Y, Ishibashi T, JACC Study Group Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 2007, 120:2665-2671. 10.1002/ijc.22614, 17304505, JACC Study Group.
17. Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, Ohrr H, Samet JM. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008, 123:1892-1896. 10.1002/ijc.23719, 18651571.
18. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, Suzuki Y, Ohmori K, Nishino Y, Tsuji I. Obesity and risk of cancer in Japan. Int J Cancer 2005, 113:148-157. 10.1002/ijc.20529, 15386435.
19. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010, 363:2339-2350. 10.1056/NEJMra0906948, 21142536.
20. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894. 10.1126/science.1141634, 2646098, 17434869.
21. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, Prokunina-Olsson L, Ding CJ, Swift AJ, Narisu N, Hu T, Pruim R, Xiao R, Li XY, Conneely KN, Riebow NL, Sprau AG, Tong M, White PP, Hetrick KN, Barnhart MW, Bark CW, Goldstein JL, Watkins L, Xiang F, Saramies J, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345. 10.1126/science.1142382, 3214617, 17463248.
22. Li H, Kilpeläinen TO, Liu C, Zhu J, Liu Y, Hu C, Yang Z, Zhang W, Bao W, Cha S, Wu Y, Yang T, Sekine A, Choi BY, Yajnik CS, Zhou D, Takeuchi F, Yamamoto K, Chan JC, Mani KR, Been LF, Imamura M, Nakashima E, Lee N, Fujisawa T, Karasawa S, Wen W, Joglekar CV, Lu W, Chang Y, et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 2012, 55:981-995. 10.1007/s00125-011-2370-7, 3296006, 22109280.
23. Wen W, Cho YS, Zheng W, Dorajoo R, Kato N, Qi L, Chen CH, Delahanty RJ, Okada Y, Tabara Y, Gu D, Zhu D, Haiman CA, Mo Z, Gao YT, Saw SM, Go MJ, Takeuchi F, Chang LC, Kokubo Y, Liang J, Hao M, Le Marchand L, Zhang Y, Hu Y, Wong TY, Long J, Han BG, Kubo M, Yamamoto K, et al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet 2012, 44:307-311. 10.1038/ng.1087, 3288728, 22344219.
24. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, Dei M, Lai S, Maschio A, Busonero F, Mulas A, Ehret GB, Fink AA, Weder AB, Cooper RS, Galan P, Chakravarti A, Schlessinger D, Cao A, Lakatta E, Abecasis GR. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007, 3:e115. 10.1371/journal.pgen.0030115, 1934391, 17658951.
25. Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity 2008, 16:1961-1965. 10.1038/oby.2008.318, 18551109.
26. Zimmermann E, Kring SI, Berentzen TL, Holst C, Pers TH, Hansen T, Pedersen O, Sørensen TI, Jess T. Fatness-associated FTO gene variant increases mortality independent of fatness-in cohorts of Danish men. PLoS One 2009, 4:e4428. 10.1371/journal.pone.0004428, 2639637, 19214238.
27. Lewis SJ, Murad A, Chen L, Davey Smith G, Donovan J, Palmer T, Hamdy F, Neal D, Lane JA, Davis M, Cox A. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One 2010, 5:e13485. 10.1371/journal.pone.0013485, 2957440, 20976066.
28. Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, Tofilon S, Agarwal S, Pasche B, Mantzoros C. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet 2011, 12:52. 3089782, 21489227.
29. Delahanty RJ, Beeghly-Fadiel A, Xiang YB, Long J, Cai Q, Wen W, Xu WH, Cai H, He J, Gao YT, Zheng W, Shu XO. Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol 2011, 174:1115-1126. 10.1093/aje/kwr233, 3246689, 21976109.
30. Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2011, 20:779-792. 10.1158/1055-9965.EPI-10-0845, 3089680, 21357378.
31. Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control 2011, 22:877-883. 10.1007/s10552-011-9760-5, 21445555.
32. Prizment AE, Gross M, Rasmussen-Torvik L, Peacock JM, Anderson KE. Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota. Pancreas 2012, 41:50-53. 10.1097/MPA.0b013e3182247625, 3241825, 22015968.
33. Wulan SN, Westerterp KR, Plasqui G. Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 2010, 65:315-319. 10.1016/j.maturitas.2009.12.012, 20079586.
34. Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 2011, 34:353-357. 10.2337/dc10-0746, 3024348, 21216863.